ASIA unversity:Item 310904400/86867
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 93288/109022 (86%)
造訪人次 : 657349      線上人數 : 468
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    題名: ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.
    作者: Chen-Yuan Lin;Hung-Jen Chen;Cheng-Chung Huang;Liang-Chuan Lai;Tzu-Pin Lu;Guan-Chin Tseng;Ting-Ting Kuo;Qian-Yu Kuok;Jennifer L. Hsu;Shian-Ying Sung;Mien-Chie Hung;Yuh-Pyng Sher
    貢獻者: 生物科技學系
    日期: 2014
    上傳時間: 2014-11-07 14:43:56 (UTC+8)
    摘要: The transmembrane cell adhesion protein ADAM9 has been implicated in cancer cell migration and lung cancer metastasis to the brain, but the underpinning mechanisms are unclear and clinical support has been lacking. Here, we demonstrate that ADAM9 enhances the ability of tissue plasminogen activator (tPA) to cleave and stimulate the function of the promigratory protein CDCP1 to promote lung metastasis. Blocking this mechanism of cancer cell migration prolonged survival in tumor-bearing mice and cooperated with dexamethasone and dasatinib (a dual Src/Abl kinase inhibitor) treatment to enhance cytotoxic treatment. In clinical specimens, high levels of ADAM9 and CDCP1 correlated with poor prognosis and high risk of mortality in patients with lung cancer. Moreover, ADAM9 levels in brain metastases derived from lung tumors were relatively higher than the levels observed in primary lung tumors. Our results show how ADAM9 regulates lung cancer metastasis to the brain by facilitating the tPA-mediated cleavage of CDCP1, with potential implications to target this network as a strategy to prevent or treat brain metastatic disease.
    關聯: CANCER RESEARCH,74(18),5229-5243.
    顯示於類別:[生物科技學系] 期刊論文




    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋